GE Healthcare Technologies Inc

GEHC is in an early Stage 1 consolidation following a terminal decline, with a Bullish Pivot Point signaling structural repair yet no clear breakout. Medium-term bias is bullish for mean reversion, but short-term price is oscillating around flat EMAs without momentum. We will defer execution, stalking for pullbacks into the lower base and EMA zone for more favorable entry.

• ↑Revenue $5.1B up 2.9% organically; backlog at $21.8B
• ↑Free cash flow $112M supports shareholder returns
• ↓Adjusted EBIT margin dropped to 13.5% due to tariffs and input costs